checkAd

     960  0 Kommentare Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study - Seite 3

    Lesen Sie auch

    Tetra Bio-Pharma Inc.
    Dr. Anne-Sophie Courtois, DVM
    Vice President, Marketing & Communications
    (438) 899-7575

    For media information, please contact:
    Daniel Granger
    Daniel.granger@acjcommunication.com
    ACJ Communication
    O: 1 514 840 7990
    M: 1 514 232 1556

    For investors information, please contact:
    investors@tetrabiopharma.com
    (438) 504-5784

    Seite 3 von 3

    Verfasst von Marketwired
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study - Seite 3 OTTAWA, ONTARIO--(Marketwired - April 4, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced the initiation of screening and enrolment activities in the Phase 3 study of its PPP001 smokable …